Laceraine® Gel Topical Wound Anaesthetic
A mixture of 4.0% w/v lidocaine hydrochloride (as monohydrate) 40.0 mg/mL, 0.5% w/v tetracaine (amethocaine) hydrochloride 5.0 mg/mL and 0.18% w/v adrenaline (epinephrine) 1.8 mg/mL as adrenaline acid tartrate.
Indication:
Topical application to superficial wounds and lacerations to provide localised surface anaesthesia for wound closure. It may be used to provide topical anaesthetic relief for cleaning, irrigation and debridement of painful minor wounds.
- Strength: 4.0% w/v lidocaine hydrochloride (as monohydrate), 0.5% w/v tetracaine (amethocaine) hydrochloride, 0.18% w/v adrenaline (epinephrine) as adrenaline acid tartrate.
- Package: Glass vial
- Phebra Code: SOL059
- Pack Size: 5 x vials
Resources:
Laceraine® Gel Application Video
To view a demonstration on the correct application of Laceraine® Gel, click the link and enter your AHPRA number (Australia). International Healthcare Providers can contact sales@phebra.com for login details.